Professor Laurence Patterson obtained his BSc (hons) in applied biology from the University of Hertfordshire and his PhD in the area of medicinal chemistry from King’s College, London. He subsequently spent several years in the pharmaceutical industry before taking up a post at De Montfort University, Leicester where he progressed to Prof of Pharmaceutical biochemistry and then on to Professor of medicinal chemistry and Head of the Department of Pharmaceutical and Biological Chemistry at The School of Pharmacy, London. Laurence is responsible for the discovery of AQ4N, a tumour hypoxia activated agent in Phase 1 Trials.

Laurence was most recently Director of the Institute of Cancer Therapeutics (ICT), University of Bradford. The ICT builds on 30 years of highly successful cancer pharmacology research in Bradford with a focus on new cancer medicines and biomarker discovery. Now, as Professor of Drug Discovery, he continues to lead and support research at the ICT and its spin out company Incanthera Ltd.

Laurence brings a good deal of technical and commercial expertise to the team along with a vast international network of contacts in the company’s key market areas. He is able to offer expert advice and technical support.